Gregory Weaver, Former EVP, CFO, & Director, Director at Atossa Therapeutics, holds 55.00 shares in Atossa Therapeutics (Ticker: ATOS), holds 4.67K shares in ATAI Life Sciences (Ticker: ATAI), holds 10.43K shares in Eloxx Pharmaceuticals (Ticker: ELOX). Most recently, Gregory Weaver Sold ― shares of Atossa Therapeutics on Nov 17, 2023 for an estimated value of 32.50K.
Gregory Weaver latest transaction was an Informative Sell of $32.50K.
What was Gregory Weaver's most profitable transaction?
Gregory Weaver’s most profitable transaction was an Informative Sell of ATOS stock on July 7, 2021. The return on the trade was 80.70%.
What is Gregory Weaver's role in Atossa Therapeutics?
Gregory Weaver's role in Atossa Therapeutics is Former EVP, CFO, & Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.